Skip to content

A Randomized Controlled Trial of Acupuncture Combined with Wen Shen Dao Tan Decoction for the Treatment of Polycystic Ovary Syndrome with Kidney-Yang Deficiency and Phlegm-Dampness Pattern

A Randomized Controlled Trial of Acupuncture Combined with Wen Shen Dao Tan Decoction for the Treatment of Polycystic Ovary Syndrome with Kidney-Yang Deficiency and Phlegm-Dampness Pattern

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001646
Enrollment
Unknown
Registered
2026-06-30
Start date
2026-07-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Interventions

Control Group:Treatment with Wenshen Daotan Decoction
Treatment group:Treatment with Wenshen Daotan Decoction combined with acupuncture

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1)Aged 18 to 40 years (inclusive of 18 and 40 years); 2)Meet the diagnostic criteria for PCOS with a disease duration of =6 months; 3)Meet the Western medical diagnostic criteria and also meet the traditional Chinese medicine diagnostic criteria for the kidney Yang deficiency and phlegm-dampness pattern; 4)Voluntarily participate in this clinical study and sign the relevant informed consent form.

Exclusion criteria

Exclusion criteria: 1)Diseases caused by other etiologies that present with clinical symptoms similar to those of PCOS; 2)Participation in other clinical trials within 3 months prior to screening; 3)Presence of severe primary diseases or malignant tumors; 4)Presence of intellectual disabilities or psychiatric disorders; 5)Presence of hematologic diseases, skin diseases, or other conditions that contraindicate acupuncture treatment; 6)Allergy to the acupuncture or herbal medicines used in this study, or fear of acupuncture; 7)Positive pregnancy test, pregnancy, or lactation.

Design outcomes

Primary

MeasureTime frame
Cycle ovulation rate;

Secondary

MeasureTime frame
Serum levels of sex hormones;Transvaginal ultrasonography;Body mass index (BMI);Waist-to-hip ratio (WHR);Body fat percentage;Acne score;

Countries

China

Contacts

Public ContactJing Chen

Shanghai Municipal Hospital of Traditional Chinese Medicine

15921440609@163.com+86 15921440609

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026